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CHAPTER I 
INTRODUCTION 
The purpose of this thesis is to identify rheumatoid factor in the 
subgingival plaque, saliva and peripheral blood, of Type III periodon-
titis patients. 
Also, this thesis will discuss the chronic antigenic stimulating 
nature of periodontal disease and its possible association with rheuma-
toid factor; an autoantibody present in diseases of chronic antigenic 
stimulation. {P.M. Johnson, W. Page Faulk, 1976, Ralph C. Williams, Jr., 
1979, James Taborn, Sara E. Walker, 1979) 
Furthermore, this thesis may result in the classification of 
periodontal disease with other chronic diseases, characterized by chronic 
antigenic stimulation which are associated with rheumatoid factor. 
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CHAPTER II 
REVIEW OF LITERATURE 
Accordingly, the etiologic agent sited in most types of periodontal 
disease seems to be microbial. Genco (1970). Two possibilities have 
been discussed relating to the tissue destructive action of chronic perio-
dontal disease: (1) direct initiation of the inflammatory response by 
injurious microbial metabolites and (2) initiation of periodontal in-
flammation by antigens of oral microorganisms setting immunopathologic 
processes into action. Genco (1970). 
For years, researchers have suggested that immunologic mechanisms 
may play a role in some form of periodontal disease. Daley, F.H., 
Healy, J.C. and Sweet, M.H. (1936). Harkavy, J. (1948). Ellison, S.A. 
and Mandel, I.D. (1963). It has been shown that the Arthus reaction 
Terner, C. (1965) and chronic allergic inflammation Rizzo, A.A. and 
Mitchell, C.J. (1966) can induce inflammatory responses in the perio-
dontal unit. 
Furthermore, a number of different antigens have been shown to 
induce inflammation upon repeated injury to the periodontium of several 
species of animals. Also human studies have shown periodontally diseased 
patients can have circulating antibodies specific for oral bacteria. 
Nisengard, R., Beutner, E.H. and Hazen, S.P. (1968) have reported 
evidence which points to hypersensitivity as an etiologic factor in 
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human inflammatory periodontal disease. Animal tests with a reagent 
prepared from actinomyces indicated that it was both reactive and safe 
for human use. Skin tests of humans with this reagent revealed a cor-
relation between the immediate hypersensitivity and the presence of 
periodontal disease. 
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Terner, C. (1965), has shown an active Arthus phenomenon success-
fully provoked in the tongue, attached gingiva, buccal mucosa of the 
rabbit, guinea pig and rat. In the attached gingiva, atypical reactions 
without necrosis occurs as frequently as the typical reaction with ne-
crosis and ulceration. Lighter animals display the typical reaction in 
a significantly higher proportion than heavier ones. 
Rizzo, A.A. and Mitchell, C.J. (1966) exposed rabbits repeatedly 
to a protein antigen by triweekly insertion of pellets containing egg 
albumin (EA) into labial gingival pockets of mandibular incisors. In 
one control group pellets containing saline were inserted in animal poc-
kets. In rabbits, whose pockets were treated with EA, the gingiva 
showed chronic inflammation with numerous plasma cells and sera contain-
ing intermediate levels of anti-EA antibody. In contrast saline treated 
rats showed normal histology and their sera did not contain antibody. 
Findings seem to indicate that antigen was absorbed into the gingiva and 
that it caused both a local and systemic immunologic response. Their 
findings support the concept that the gingival plasmacytosis of chronic 
periodontal disease is brought about by local absorption of bacterial 
antigens. 
Mergenhagen, S.E. and Rizzo, A.A. (1961) injected 1.0 ml of horse 
serum every other day subcutaneously in the intrascapular area of New 
Zealand rabbits. After 3,5, and 6 sensitizing injections - animals were 
challenged intramucosally in the gingiva and palatal mucosa. Rabbits 
which were sensitized with as few as three injections over a six day 
period showed, mucous with edema and plasma cell infiltration. Nonsen-
sitized animals showed a minimal response. Authors concluded allergic 
type mechanisms may play an important role in the development of the 
pathologic lesion of periodontal disease. 
Beutner, E.H., Trifthause, C., Nisengard, R. and Frinnan, A.J. 
(1966) sensitized guinea pigs, by systemic immunization with bovine 
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serum albumin in complete Freunds adjuvant. Subsequently the animals 
were challenged by a intragingival injection with the same antigen. Fol-
lowing challenge, the teeth had increased mobility, osteoclastic resorp-
tion and gingiva appeared inflamed as compared with control animals. The 
pathologic changes observed in the gingiva of sensitized guinea pigs 
following gingival challenge with the sensitizing antigen resembles 
those seen in inflammatory types of human periodontal disease. 
Mergenhagen, S.E., de Arajio, W.C. and Varah, E. (1965) utilizing 
a hemolysis procedure employing soluble antigen extracted from a strain 
of Leptotrichia buccalis, showed hemolytic antibody to L. buccalis in 
the sera of adult individuals. This experiment indicated that man may 
have the capability of developing antibodies to somatic antigens. 
Evans, R.T., Spaeth, S. and Mergenhagen, S.E. (1966) demonstrated 
mice immunized intraperitoneally with r. alcalescens in complete Freund•s 
adjuvant developed high titers of bactericidal antibody in both serum and 
5 
ascitic fluid. Immunization of rabbits with serum sensitive strains of 
V. alcalescens produced high titers of specific bactericidal antibody but 
did not affect the levels of this antibody to serum sensitive strains of 
f. coli or Salmonella typhosa. Sera from adult patients with periodontal 
disease when compared to normal adult sera were found to contain increas-
es in bactericidal antibody to f. polymorphum an organism associated with 
periodontitis and Vincent's infection. 
The potential for an immunologic mechanism to play a role in perio-
dontal pathology is clear. Antigens are abundant in dental plaque and 
periodontal tissues can exhibit immunologic reactivity, moreover, ex-
perimental periodontal disease has been induced in animal systems by 
immunologic processes. Genco (1970). 
A commonly found mitogen-antigen in dental plaque has been shown 
to be endotoxin, a macromolecular complex of lipopolysaccharide derived 
from the outermost membrane of gram negative bacteria. Simon, B.I., 
Goldman, H.M., Ruben, M.P., Broitman, S., Baker, E. (1972). Mergenhagen, 
W.E., Bladen, H.A. and Hsu, K.C. (1966). 
The presence of lipopolysaccharides in dental plaque and periodon-
tal disease has been associated with the pathogenesis of periodontal 
disease. Simon, B., Goldman, H., Ruben, M. and Baker, E. (1969). Simon, 
B., Goldman, H., Ruben, M., Broitman, S., and Baker, E. (1972). 
The relationship of endotoxin and the etiology of periodontal 
disease becomes of interest when one notes that endotoxin is a potent in-
flammatory agent. 
Bacterial lipopolysaccharides have the capacity to exhibit 
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biological effects on the immune system. Included in these effects are 
mitogenicity, a phenomenon restricted to B lymphocyte cell population; 
Gery, I., Kruger, J. and Spiessel, S.Z. (1972}, Andersson, J., Moller, G. 
and Sjoberg, 0. (1972), adjuvanticity capable of antibody formation John-
son, A.G., Gaines, S. and Landy, M. (1956}, Neter, E. (1969), and high 
immunogenic potential, in that low concentrations will cause a specific 
antibody response in experimental animals. Landy, M. and Baker, P.J. 
(1966) Nossal, G.J.V. and Ada, G.L. (1971). 
Surprisingly LPS has the capability of circumventing thymus derived 
T-cell helper function, which otherwise is required for initiation of 
antibody response to T-cell dependent antigens. Schmidtke, J. and Dixon, 
F. J. (1972). 
The LPS macromolecule has been chemically characterized into three 
regions: Luderitz, 0., Westphal, 0., Staub, A.M. and Nikaido, H. (1971)., 
(1) the 0 polysaccharide which is linked to (2) the core polysaccharide 
which is in turn linked to (3) a lipid A by a trisaccharide of 2-Keto-3-
deoxyoctanoic acid. It has been demonstrated the mitogenicity and adju-
vanticity were actions attributed to the lipid region of the molecule; 
whereas, the antigenic specificity was related to the polysaccharide 
region. Luderitz, 0., Westphal, 0., Staub, A.M. and Nikaido, H. (1971). 
It has been demonstrated that LPS acting independently of antibody 
has the capacity to trigger the alternate complement pathway of inflamma-
tion. See figure 1. Roitt, I.M. and Lehner, T. (1980). 
Furthermore, characteristic of some chronic antigenic stimulating 
diseases is polyclonal B-cell lymphocyte activation. Freeman, R.R. and 
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CLASSICAL ALTERNATIVE 
C3 ACTIVATION 
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Microbial polysaccharide 
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! 
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/ 
~F ( + 'trypsin') 
C3c C3d 
Figure l. Similarity of Alternate and Classical Pathways of Inflammation. 
Parish, C.R. (1978), found preparations of Plasmodium berghei Kl73 and 
Plasmodium yoelii 17X have activity in vivo, and that the treatment in 
mice with the mitogenic supernatant results in polyclonal 8 cell activa-
tion and non-specific IgM synthesis. 
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Greenwood, 8.M. (1974), has hypothesized that the increased syn-
thesis of immunoglobulin production seen in patients with African trypan-
osomiasis could be the consequence of, polyclonal 8-cell lymphocyte ac-
tivation. 
A technique for the detection of polyclonal antibody production has 
been demonstrated by Cunningham. Cunningham, A.J. and Szenberg, A. 
(1968). Mice injected with 8-cell mitogen lipopolysaccharide from Es-
cherichia coli, showed the production of polyclonal 8-cell activation 
measured by splenic plaque forming cells (PFC). 
Kobayakawa, T., Louis, J., Izui, S. and Lambert, P.H. (1979), con-
firmed that the injection of Trypanosoma brucei (T. brucei) in mice leads 
to a nonspecific polyclonal 8-cell lymphocyte activation. Their conclu-
sions were based first on the observation that the number of lymphocytes 
in the spleens of infected mice increased fifteen times three weeks after 
the infection, and secondly, the cells producing antibodies against a 
variety of antigens appear in the spleen of infected mice. Furthermore 
these nonspecific PFC responses were composed of only direct PFC, sug-
gesting that the secreted antibodies are of the IgM class. The data con-
firm the conclusion of Hudson, K.M., Byner, C., Freeman, J. and Terry, 
R.J. (1976), when an increase in the backround PFC directed against T. 
brucei in lymphoid tissues was demonstrated. 
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Kobayakawa further demonstrated that autoantibodies produced during 
the course of the parasitic infection, seemed to belong to the IgM class. 
Development of these autoantibodies is parallel to the growth of poly-
clonal antibody production. These findings suggest the formation of auto-
antibodies could be a consequence of the polyclonal B lymphocyte activa-
tion. Kobayakawa, T., Louis, J., Izui, S. and Lambert, P.H. (1979). 
Similar immune reactions have been demonstrated to occur in anti-
genic challenge with bacterial lipopolysaccharides. Izui, S. (1979) 
demonstrated the production of rheumatoid factors (autoantibodies) in 
several strains of mice, including athymic nude mice. Significant IgM-
rheumatoid factor activity was observed in seven eight week old female 
mice injected intraperitoneally with 50 ~g of LPS from Salmonella typhi-
murium on days 0,7 and 14. Concentrations of IgM-RF increased continu-
ously up to day 21, which was seven days after the last injection, but 
decreased rapidly after this time. Matched control mice receiving saline 
did not show significant changes in IgM-RF during the same period. The 
ability of LPS to induce IgM-RF was then studied in five other strains 
of mice and all responded to LPS injections by forming IgM-RF. 
Gargiulo, A.V., Toto, P.D., Gargiulo, A.W. and Robinson, J. (un-
published) demonstrated, by latex slide agglutination, rheumatoid factor 
in peripheral blood of nine, 12 week old, male Sprague-Dawley rats. Rats 
were injected in the palatal gingiva with 50 ~g and 100 ~g doses of LPS 
from Salmonella typhimurium on day 0,9 and 16. Non-injected rat and 
vehicle control rat (injected with 0.085% sterile saline) demonstrated 
no rheumatoid factor in peripheral blood. 
According to Kobayakawa, T., Louis, J., Izui, S. and Lambert, P.H. 
(1979), the role of lipid A component of endotoxin in the genesis of 
of polyclonal B-cell activation is a possibility. 
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Morrison, D.C., Betz, S.J. and Jacobs, D.M. (1976), have shown mice 
lymphocytes to react mitogenically to the lipid A associated protein in 
LPS. 
Further evidence by Izui, S. (1979) demonstrates that the active 
portion of the LPS molecule that is responsible for the RF induction 
appears to be the phospho-lipid fraction containing lipid A; since the 
highest levels of RF induced in mice correlated with injection of LPS 
that contained the most lipid A per molecule. 
Such a correlation has been demonstrated by Chiller, J.M., Skid-
more, B.J., Morrison, D.C. and Weigle, W.O. (1973), when induction of 
DNA synthesis was measured to show lipid A was mitogenic for bone marrow 
derived lymphocytes obtained from spleens of congenitally athymic mice. 
Izui, S. (1979). 
Lipid A has been shown to be structurally composed of a phosphory-
lated D-acetyl glucosamine to which fatty acids (lauric, myristic, 
palmitic and 3-hydroxy myristic) are ester or amide linked. Rietschel, 
E.T., Gottert, H., Luderitz, 0. and Westphal, 0. (1972) have demonstrated 
removal of the ester-linked fatty acids by alkaline hydrolysis does 
eliminate the B-cell lymphocyte mitogenic stimulus obtained from the 
total molecule. 
Since bacterial products, specifically lipopolysaccharides, have 
been shown to induce polyclonal 8-cell activation and enhance production 
of IgM rheumatoid factor in chronic antigenic stimulating diseases; a 
review of rheumatoid factor and its association in chronic disorders is 
necessary. 
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Meyer, K. (1922) was the first to discover rheumatoid factor (RF), 
when he showed sensitized sheep red blood cells were agglutinated by 
sera of rheumatoid arthritis patients. Since, research in the field of 
rheumatoid arthritis and diseases of chronic antigenic stimulation asso-
ciated with rheumatoid factor has been intensely and widely published. 
Rheumatoid factors have been demonstrated to be antibodies (auto-
antibodies) directed against altered or native gamma globulin. The most 
common rheumatoid factor occurs as IgM immunoglobulin, which has specifi-
city for antigenic determinants of the Fe fragment of human or animal 
IgG. Taborn, J.D., and Walker, S.E. (1979). Williams, R.C. (1979). 
Immunoglobulin classes of IgG and IgA may also have specificity for IgG. 
Torrigiani, G. and Raitt, I.M. (1967). 
Although the detection of rheumatoid factor in the serum may sup-
port a diagnosis of human rheumatoid arthritis, its presence may be asso-
ciated with many other chronic antigenic stimulating diseases. (See 
Table I.) 
Rheumatoid factors have a wide range of specificities for IgG. At 
least seven antigenic sites on the IgG molecule react with rheumatoid 
factor. Taborn, J.D. and Walker, S.E. (1979). Rheumatoid factor reacts 
most commonly with antigenic groupings of IgG that have been buried in 
the native molecule. Stage, D.E., and Mannik, M. (l973).The so-called 
"hidden determinants" may be revealed by unfolding of the IgG molecule 
TABLE I 
CHRONIC ANTIGENIC STIMULATING DISEASES 
ASSOCIATED WITH RHEUMATOID FACTOR 
Normal persons (2 to 4% of the population) 
Rheumatoid arthritis 
Relatives of rheumatoid arthritis patients 
Aging (10 to 20% positive over age 65) 
Systemic lupus erythematosus 
Sjogren•s Syndrome 
Scleroderma 
Dermatomyositis 
Sarcoidosis 
Leprosy 
Dysproteinemias and paraproteinemias 
Liver disease (infectious hepatitis, biliary cirrhosis) 
Syphilis 
Idiopathic pulmonary fibrosis 
Pneumoconiosis 
Acute pulmonary tuberculosis 
Acute viral infections 
Parasitic diseases 
Following prophylactic vaccinations 
Subacute bacterial endocarditis 
Diabetes mellitus patients on insulin therapy 
Psychiatric disorders (schizophrenia, endogenous depression) 
Following multiple blood transfusions 
Parenteral narcotic addiction 
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in denaturation or by the reaction of IgG with unknown antigen. Taborn, 
J.D. and Walker, S.E. (1979). 
The biologic properties of rheumatoid factor is unclear. Produc-
tion of RF may be caused by an unknown process which changes the patients 
IgG and makes it autoimmunogenic. This process may be a chronic infec-
tion, an acquired abnormality in the IgG causing it to aggregate spontan-
eously and thereby becoming immunogenic. Taborn, J.D. and Walker, S.E. 
(1979). There may be an unknown factor in rheumatoid arthritis which 
breaks down IgG, thereby forming fragments which stimulate formation of 
anti-IgG antibody. More recently it has been shown in vitro, that B-
cells programmed to synthesize RF are present in both normal and rheuma-
toid arthritis B-cell lymphocyte repertoires, but are preferentially ex-
pressed in rheumatoid arthritis. Koopman, W.J. and Schrohenloher, R.E. 
(1980). 
The screening technique most commonly employed to identify the pre-
sence of rheumatoid factor is a latex slide agglutination test, first 
described by Singer, J.M. and Plotz, C.M. (1956). 
The principle of the latex slide agglutination method for the 
demonstration of rheumatoid factor involves the use of an indicator sys-
tem containing a large number of IgG molecules. The IgG is either bound 
to carrier particles, such as latex, bentonite, erythrocytes or the IgG 
molecules are simply aggregated by heat denaturation or other means. The 
presence of rheumatoid factor in serum is recognized by agglutination, 
precipitation or flocculation of the respective IgG containing indicator 
system. Waller, M.V. and Vaughn, J.H. (1956). Serial dilutions of the 
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serum samples provide an estimate of the quantity of the rheumatoid factor 
in terms of titer. 
Of course, other methods for the detection of rheumatoid factor are 
available. Radioimmunoassay involves the binding of radioactively la-
belled antigen to a fixed amount of antibody which can be partially in-
hibited by addition of unlabelled antigen. The inhibition can then be 
used as a measure of the unlabelled material added. Sato, M., Kasukawa, 
R., Murai, T. and Yoshida, T. (1977) have demonstrated the detection of 
rheumatoid factors through solid-phase radioimmunoassay. Rheumatoid 
factors of IgG and IgM class were detected by means of solid-phase radio-
immunoassay using formalinized sheep erythrocytes sensitized with rabbit 
anti-sheep erythrocyte serum and 125 I-labelled anti-human IgG or anti-
human IgM antibody. 
Another very sensitive and precise method for the detection of 
rheumatoid factor is the enzyme linked immunosorbent assay (ELISA). 
Voller, A., Bidwell, D. and Bartlett, A. (1977). The basis of the ELISA 
depends on two assumptions: 1) that antigen or antibody can be attached 
to a solid-phase support yet retain immunological activity and 2) that 
either antigen or antibody can be linked to an enzyme and the complex 
retain both immunological and enzymatic activity. Vejtrop, M., Hoier-
Madsen, M. and Halberg, P. (1979), demonstrated that the ELISA was well 
suited for quantitative routine determination of IgM-RF. Gripenberg, M., 
Wafin, F., Isomaki, H. and Linder, E. (1979), have developed a simple 
enzyme linked immunosorbent assay, using human IgG as antigen, and found 
good agreement betw~en the results and reproducibility. 
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Some investigators have suggested a protective role for rheumatoid 
factor. It has been postulated that rheumatoid arthritis has a viral 
etiology, and that rheumatoid factor may have antiviral properties in 
vitro. It is thought that viral neutralization may be enhanced by the 
addition of human IgG rheumatoid factor. Interestingly, Ashe, W.K. and 
Nothens (1971) have shown the addition of IgM rheumatoid factors facili-
tates neutralization of virus by antiviral antibody, blocking all anti-
genic sites in the virus available for cell penetration or fixation. 
Rheumatoid factor also influences chemotactic activity and phago-
cytosis. The addition of rheumatoid factor, aggregated IgG and comple-
ment to a suspension of neutrophils, produced increased chemotactic 
activity compared to aggregated IgG and serum. Borel, J.F., Sorkin, E. 
and Loewi, G. (1971). 
However, in another in vitro system phagocytosis of bacteria was 
inhibited by rheumatoid factor. Messner, R.P. (1968). Further, it was 
shown white blood cells which have ingested rheumatoid factor IgG complex 
have reduced ability to phagocytose bacteria. 
Animal studies have shown, that rheumatoid factor can be induced 
with the use of prolonged intravenous hyperimmunization with coliform 
bacteria. Christian, C.L. (1963) or immunization with autologous gamma 
globulins. Catsoubi, E.A. (1965). 
Rabbits immunized with autologous gamma globulin produced anti-
gammaglobulin antibody with primary specificity for human rather than 
rabbit IgG. Similarly, injection of a rabbit with autologous immuno-
globulin complexes in complete Freund•s adjuvant stimulated production of 
an anti-gammaglobulin reaction with human IgG and rabbit IgG. Rabbit 
rheumatoid factors react specifically with the Fe fragment of IgG and 
pepsin digested IgG. The above phenomenon was found in serum from rab-
bits receiving long term immunization of cell wall carbohydrate derived 
from streptococci. Osterland, C.K. (1966). 
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Restifo, R.A. (1965) demonstrated the induction of acute arthritis 
by intra-articular injection of autologous IgG in rheumatoid arthritis 
patients, who have rheumatoid factor; while the same injection in sero-
negative rheumatoid arthritic patients did not cause synovitis. In a 
similar study, prolonged intravenous infusion of rheumatoid factor had 
no adverse effect on normal subjects. 
The proposed mechanism of tissue destruction in rheumatoid arthritis 
is the fixation of complement by rheumatoid factor-IgG complex which is 
engulfed by polymorphonuclear leukocytes. The leukocytes then indirectly 
release the tissue destroying enzymes. 
In Sjogren's Syndrome with or without rheumatoid arthritis, the in-
cidence of serum rheumatoid factor approaches one hundred percent. Bunim, 
J.J., Buchanan, W.W., Wertlake, P.T., Sokoloff, L., Block, K.J., Beck, 
J.S. and Alepa, F.B. (1964). No other population of patients, including 
those with rheumatoid arthritis, have such a high frequency of this auto-
antibody. Anderson, L.G., Cummings, N.A., Aosfsky, R., Hylton, M.B., 
Tarpley, T.M., Tomasi, T.B., Wolf, R.O., Schall, G.L. and Talal, N. (1972). 
In vitro studies utilizing lip biopsy specimens, suggest lymphoid cells 
infiltrating the salivary glands in Sjogren's Syndrome, synthesize large 
quantities of IgM and IgG, some with an anti IgG or rheumatoid factor 
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activity. Clinically, macroglobulin, a characteristic of Waldenstrom Syn-
drome appears to play a prominent role in the lymphoproliferative process 
in some patients with Sjogren's Syndrome. The above report supports the 
coexisting Sjogren's Syndrome and Waldenstrom's macroglobulinemia re-
ported in the literature. Pinkus, G.S. and Dekker, A. {1970). White-
house, A.C., Buckley, C.E. III, Nagaya, H. and McCarter, J. (1967). 
Malsville, J., Heid, F., Rousselot, P., Bergoend, H., Grosshans, E. and 
Araujo, A. ( 1967). 
Chronic antigenic stimulation is characteristic of both periodontal 
disease and rheumatic diseases. The method of tissue destruction by poly-
morphonuclear leukocytes associated with both of these chronic disorders 
is similar. Furthermore, the association between rheumatic diseases, dis-
orders of chronic antigenic stimulation, and rheumatoid factor has well 
been established in the medical literature. Is there an association be-
tween periodontal disease, a disease of chronic antigenic stimulation, 
and rheumatoid factor? This is the purpose of the present investigation. 
The association of periodontal disease with other diseases of 
chronic antigenic stimulation in which polyclonal antibodies are produced 
containing rheumatoid factor appears promising. It is the purpose of 
this study to determine the presence of rheumatoid factor in the gingival 
crevice of patients with moderate to advanced periodontitis. 
CHAPTER III 
MATERIALS AND METHODS 
Materials 
1. Latex Human IgG Slide Agglutination Test- 11 Rheumanosticon 11 for the 
determination of rheumatoid factor, by Organon, West Orange, New 
Jersey. 
Kit Contents: 
a. Latex reagent-particle size, 0.81 microns 
b. Glycine buffered concentrate (glycine buffered saline) 
c. Positive serum control 
d. Negative serum control 
e. Dispenstirs, designed to deliver 0.03 ml 
f. Black background slide 
2. 12 mm x 75 mm sterile polystyrene tubes (Cole Parmer Instrument Com-
pany, Chicago, I 1 . ) 
3. Disposable 0.5 ml microcentrifuge tubes (Cole Parmer Instrument Com-
pany, Chicago, Il. 
4. Centrifuge 
5. Blood lancets (Scientific Products, McGaw Park, Il.) 
6. 70% isopropyl alcohol 
7. Non-containing IgG, or blank latex beads, 0.80 microns (Sigma Labora-
tories, St. Louis, Missouri) 
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8. The Colorimetric Determination of Albumin (Sigma Laboratories, St. 
Louis, Missouri 
Human Subjects: 
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Thirty Type III Periodontitis patients, selected by using the American 
Dental Association Classification for Periodontal disease. 
Classification: 
Type I - Gingivitis (shallow pockets, no bone loss) 
Type II - Early periodontitis (moderate pockets, 
minor to moderate bone loss, 
satisfactory topography, usually no 
tooth mobility) 
Type III - Moderate periodontitis (moderate to 
deep pockets, moderate to severe bone 
loss, unsatisfactory bone topography) 
Type IV - Advanced periodontitis (deep pockets, 
severe bone loss, advanced mobility 
patterns, usually missing teeth, may 
become prosthetic reconstruction case) 
Methods 
A. Subgingival plaque and fluid were tested for rheumatoid factor 
as described below: 
1. Subgingival contents were sampled from a periodontal 
pocket, 5-6 mm in depth, of a Type III periodontitis 
patient, with the use of a sterile curette. 
2. The subgingival plaque sample was sonicated in 0.18 ml 
of glycine buffered slaine (GBS), contained in a 
disposable 0.5 ml microcentrifuge tube. 
3. The microcentrifuge tube containing the sonicated 
sample was placed in a 12 mm x 75 mm polystyrene tube, 
and centrifuged at 3,675 rpm for ten minutes to re-
move particulate matter. 
4. The initial plaque dilution was heat inactivated at 
56°C for thirty minutes, in order to inactivate 
complement components. 
5. 0.03 ml of the initial dilution was placed on the 
black background slide issued in the kit, and 
mixed in a figure eight configuration with 0.03 ml 
of latex containing -IgG for one minute at room 
temperature. Tests will be scored as positive on 
flocculation or negative in the absence of flocculation, 
according to the manufacture's direction. All initial 
dilutions yielding a positive test were then diluted 
1:20 and retested in the same manner as described 
above. 1:20 dilutions were made by pipetting 0.1 ml 
of initial plaque dilution and placing it in 1.9 ml of 
GBS. 
6. Positive and negative controls accompanied the above 
reactions as provided in the test kits. 
Positive control - a dilution of human sera 
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containing rheumatoid factor 
causing flocculation of IgG 
adsorbed latex particles. 
Negative control - dilution of human sera 
containing no detectable 
rheumatoid factor, which will not 
flocculate latex particles 
adsorbed with IgG. 
Negative control - latex particles not containing 
adsorbed IgG, that is blank particles, 
which do not flocculate with sera 
with or without rheumatoid factor. 
B. Saliva was tested for rheumatoid factor as described below: 
1. 0.25 ml of human saliva was drawn from pooled saliva 
from the floor of the mouth. This sample was placed 
in a 0.5 ml microcentrifuge tube. 
2. The saliva sample was heat inactivated at 56°C for 
thirty minutes and centrifuged at 3,675 rpm for 
ten minutes. 
3. 0.03 ml of the centrifuged saliva sample was placed 
on the black background slide and assayed with 0.03 ml 
of latex containing IgG and mixed in a figure eight 
configuration. Any initial samples yielding a 
positive result were diluted 1:10 and re-tested in 
the same manner, and examined for evidence of 
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flocculation. 
4. Tests were scored as in step 5 of subgingival plaque 
testing, and similar controls were utilized as 
described in step 6 under subgingival palque testing. 
5. Stimulated pooled saliva was also obtained from ten 
full denture patients, wearing full denture prosthesis. 
These patients were utilized as controls. 
C. Blood was tested as described below: 
1. The patient•s middle finger was wiped clean with a 
70% isopropyl alcohol. A finger puncture was made 
with a blood lancet provided by Scientific-Products. 
2. The blood was not milked from the finger but allowed 
to flow, and it was collected in a sterile dispenstir, 
provided in the test kits. 0.03 ml of blood was drawn 
through the dispenstir, which is approximately equal 
to one squeeze of the dispenstir between the thumb and 
forefinger. 
3. One free-falling drop was diluted in 0.25 ml of GBS in a 
12 mm x 75 mm test tube. This represents a 1:10 dilution. 
4. 0.03 ml of the 1:10 dilution is assayed with 0.03 ml of 
IgG containing latex beads on the black background slide 
and mixed in a figure eight configuration, and examined 
for flocculation. Any positive tests are further diluted 
to 1:20 in GBS and retested for rheumatoid factor. 
5. Scores and controls were made as previously described. 
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D. Albumin concentration control: 
A Colorimetric Determination of Albumin (Sigma Labs. St. 
Louis, Missouri), was performed on all subgingival plaque 
samples to determine albumin concentrations. In order to 
standardize plaque samples through protein concentration, 
albumin can serve as an indicator of serum protein component 
of gingival plaque and fluid. 
In the above colorimetric test, Rodkey (1965) determined 
bromocresol green (BCG) will bind to albumin and not to 
other proteins. The intensity of the color of the albumin-
BeG complex is measured at 630± 5nm in a Coleman 6/35 
spectrophotometer. 
Procedure 
1. Sterile test tubes 12 x 75 mm were labelled, blank, standard, 
subgingival plaque 1, subgingival plaque 2 ... subgingival 
plaque 30. 
2. To all tubes 5.0 ml Albumin Color Reagent, Stock No. 630-2 
was added. 
3. To blank test tubes, 20 ~1 of 0.85% sodium chloride solution 
was added. 
To the standard, 20~1 Protein Standard Solution, Stock No. 
540-10 was added. 
To each tube labelled subgingival palque, 20 ~1 of the sub-
gingival plaque dilution was added. 
4. All tubes were vortexed for thirty seconds and allowed to 
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stand at room temperature for 10 min. 
5. Absorbance of blank, standard and subgingival plaque was read 
at 630 nm., in a Coleman Spectrophotometer 6/30. 
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CHAPTER IV 
RESULTS 
In this investigation, the patient sample size numbered thirty. 
There were twenty males and ten females, whose ages ranged from 28-65 
years. The mean age was 45.1 years. 
All patients selected for this study were classified as having a 
Type III periodontal condition and without history of rheumatic diseases. 
Table II describes the results obtained from subgingival plaque in 
1.8 ml of GBS, and serum diluted in GBS 1:10 and 1:20, when assayed with 
IgG-containing latex beads and blank (non-containing IgG latex beads) as 
a parallel control, for the detection of rheumatoid factor. 
Negative and positive serum controls all were negative or positive, 
respectively. Of the experimental subjects, 66.6% showed positive agglu-
tinations with bacterial plaque; 83.3% with serum 1:10 and 6.6% with 
serum 1 :20. 
Table III describes the results obtained from stimulated saliva and 
saliva diluted in GBS 1:10, when assayed with IgG-containing latex beads 
and blank beads as a parallel control, for the detection of rheumatoid 
factor. Of the experimental subjects 100% of the stimulated undiluted 
whole saliva samples were positive for RF but only 40.0% were positive at 
1:10 dilution. Control saliva obtained from ten edentulous denture pa-
tients wearing full denture prosthesis, ranging from 59-88 years of age, 
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was assayed as described above for the thirty experimental patients. 
50% of the stimulated samples were positive for RF; however, at 1:10 
dilution only one sample or 10% was positive. 
26 
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TABLE II 
Positive and Negative Reactions Tabulated 
For Detection of Rheumatoid Factor 
Patient Subgingival Serum Serum Neg. Pos. Blank 
No.-Age plaque/l.88cc 1 :1 0 1 :20 Cont. Cont. Beads 
GBS 
1 - 31 + + + 
2 - 29 + + + 
3 - 60 + + + 
4 - 46 + + + 
5 - 51 + + + 
6 - 39 + + + 
7 - 51 + + + 
8 - 46 + + + 
9 - 58 + + 
10 - 32 + + 
11 - 32 + 
12 - 33 + 
13 - 33 + + 
14 - 47 + + + + 
15 - 28 + + + + 
16 - 33 + + + 
17 - 52 + + 
18 - 65 + + + 
19 - 37 + + 
20 - 61 + + + 
21 - 28 + 
22 - 65 + + 
23 - 41 + + 
24 - 45 + + + 
25 - 31 + + + 
26 - 55 + + + 
27 - 52 + + 
28 - 63 + + + 
29 - 52 + + + 
30 - 57 + + 
No. of 
Agglutinations 20 25 2 0 30 0 
Percent 
Agglutination 66.6% 83.3% 6.6% 0% 100% 0% 
Mean .66 .83 .06 0.0 1.0 0.0 
Standard 
Deviation ±.47 ±.37 ±.25 ±0.0 ±0.0 ±0.0 
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TABLE III 
Positive and Negative Reactions Tabulated 
For Detection of Rheumatoid Factor 
Patient Stimulated Saliva Negative Positive Blank 
No.-Age Saliva 1:10 Control Control Beads 
1 - 31 + + + 
2 - 29 + + 
3 - 60 + + 
4 - 46 + + 
5 - 51 + + + 
6 - 39 + + 
7 - 51 + + 
8 - 46 + + 
9 - 58 + + 
10 - 32 + + + 
11 - 32 + + 
12 - 33 + + 
13 - 33 + + 
14 - 47 + + + 
15 - 28 + + 
16 - 33 + + 
17 - 52 + + 
18 - 65 + + + 
19 - 37 + + + 
20 - 61 + + 
21 - 28 + + + 
22 - 65 + + 
23 - 41 + + + 
24 - 45 + + 
25 - 31 + + + 
26 - 55 + + + 
27 - 52 + + + 
28 - 63 + + 
29 - 52 + + 
30 - 57 + + + 
No. of 
Agglutinations 30 12 0 3 0 
Percent Positive 
Agglutinations 100% 40.0% 0% 100% 0% 
Mean 1.0 .40 0.0 1.0 0.0 
Standard 
Deviation ±0 ±.49 ±0.0 ±0.0 ±0.0 
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TABLE IV 
Control Saliva 
Ten Full Denture Patients 
Patient Stimulated Saliva Negative Positive Blank 
No.-Age Saliva 1:10 Control Control Beads 
1 - 88 + + + 
2 - 65 + + 
3 - 67 + + 
4 - 78 + 
5 - 59 + 
6 - 63 + 
7 - 61 + + 
8 - 64 + + 
9 - 66 + 
10 - 68 + 
No. of 
Agglutinations 5 1 0 10 0 
Percent Positive 
Agglutinations 50% 10% 0% 100% 0% 
Mean .50 . 10 0.0 0.0 0.0 
Standard 
Deviation ±.52 ±.31 ±0.0 ±0.0 ±0.0 
Albumin concentration in each subgingival 
plaque dilution as determined by the Colorimetric 
Determination of Albumin, are listed in Table V. 
Concentrations were calculated as follows: 
Albumin-subgingival Absorbance of subgingival 
plaque dilution (gm/100 ml) = ~Pl;...::.a:....:~g~..=:u.;;-e.....;d::...:i...:..l..:;.ut..::..i:..::o:..;:n...,..----.--.,...­
Absorbance of Standard 
albumin 
Concentration of the 
Standard albumin (gm/100 ml} 
For example: the calculated concentration of albumin 
in the subgingival plaque dilution of 
patient no. 19, was determined as follows: 
Albumin-subgingival .02 
plaque dilution (gm/100 ml) = .45 
x 5.0 gm/100 ml 
= .22 gm/100 ml 
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TABLE V 
Albumin Concentration Determined by Color-
metric Determination of Albumin In Diluted 
Subgingival Plaque 
Patient No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
Absorbance 
subgingival 
plaque dil. 
. 015 
.05 
.05 
. 01 
.015 
.05 
.015 
.05 
.015 
.012 
. 01 
.05 
.012 
.01 
.08 
.013 
.016 
.015 
.02 
.018 
• 021 
.015 
.06 
.025 
.018 
. 031 
.013 
. 01 
. 015 
.02 
Albumin cone. 
in subgingival 
plaque dil. 
(gm/1 OOml) 
. 16 
.55 
.55 
.11 
. 16 
.55 
.16 
.55 
. 16 
.13 
.11 
.55 
. 13 
.11 
.88 
. 14 
• 17 
.16 
.22 
.20 
.23 
.16 
.66 
.27 
.20 
.34 
. 14 
.11 
. 16 
.22 
Mean albumin concentration = .27 gm/lOOml 
Standard deviation = ± .20 gm/lOOml 
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CHAPTER V 
DISCUSSION 
Diluted subgingival plaque, sera and saliva of patients with Type 
III periodontal disease show evidence of rheumatoid factor by the macro-
scopic agglutination between anti-IgG globulins or rheumatoid factors and 
the IgG containing latex beads. 
Blank latex beads failed to agglutinate when assayed with subgingi-
val plaque, serum or saliva. This demonstrates the latex beads themselves 
did not non-specifically agglutinate to some moiety present in the test 
samples. 
Concentration of albumin in diluted subgingival plaque samples 
ranges from 0.11 to 0.88 g/lOOm. Mean and standard deviation of albumin 
concentration was determined to be 0.27± 0.20 g/100 ml. A significant re-
duction of albumin in the subgingival plaque samples was evident when 
compared to the normal serum albumin levels ranging from 3.8-5.1 g/100 ml. 
In this investigation, even though the plaque samples were diluted, re-
duction of albumin levels in the gingival exudate as compared with serum 
levels seems to be in agreement with the findings of Brill and Bronnenstan 
(1960) and Schenkein and Genco (1977). The significance of the presence 
of albumin in diluted subgingival plaque samples, indicates the presence 
of serum proteins in crevicular fluid. For example, Shillitoe and Lehner 
(1972) have described the concentrations of IgG, IgA, IgM and c3 in 
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gingival fluid from periodontally diseased patients to be well below 
their respective serum levels. 
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Furthermore, positive agglutination reactions in subgingival plaque 
corresponded to low concentrations of albumin, suggestive of rheumatoid 
factor production locally and not from factors entering the gingival crev-
ice from the serum. See Figure 2. 
In eighteen subjects with chronically inflamed gingiva Schenkein 
and Genco (1977) have shown IgG, IgM and IgA in decreased concentration 
in gingival fluid as compared to serum levels. 
Experimental subjects with chronic periodontitis have rheumatoid 
factor in their pooled whole saliva. This may be of positive diagnostic 
significance as saliva of edentulous patients are positive only in 50% of 
the patients. Moreover, dilution of control saliva results in only 1 in 
10 positive. Perhaps edentulous patients may have had chronic periodon-
titis prior to full denture prosthesis; and this is the reason for the 
residual dilute rheumatoid factor. Only through additional studies may 
this point be answered. 
Blank latex beads were unreactive with control saliva; this corres-
ponds well with the results obtained with diluted subgingival plaque. 
In analyzing agglutination reactions between plaque samples and 
1:10 serum samples, all subjects with periodontitis demonstrating posi-
tive reactions in plaque (20 of 30) also showed positive reactions in 
1:10 serum except one individual. This seems interesting, as none of the 
subjects with periodontitis had rheumatoid arthritis. As a serum dilu-
tion of 1:20 demonstrating agglutination is essential in supporting a 
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Figure 2 
7 
. 
Q) 
s.. ::I 
0 0" 
4- ttl 
....- 6 Ul 0.. 
s::: 
0 ....-
...... ttl 
+> > 
u ...... 
ttl O'l 
Q) s::: 5 0::: ...... 
O'l 
s::: ..0 
0 ::I 
...... (/) 
+> 
ttl "'0 
s::: Q) 4 
...... +> 
+> ::I 
::I ....-
....-
...... 
O'l Cl 
O'l 
c:r:: s::: 
...... 3 Q) 
> s.. 
...... 0 
.j..) +> 
...... u 
Ul ttl 
0 u.. 
0.. 2 
"'0 
4- ...... 
0 0 
.j..) 
s.. ttl 
Q) E 
..0 ::I 
E Q) 1 
::I ..s::: 
z: 0::: 
0 . 10 .20 .30 .40 .50 .60 .70 .80 .90 
Concentration of Albumin in 
Diluted Subgingival Plaque 
(g/lOOml) 
35 
diagnosis of rheumatic disease. Substantiating this fact, is the observa-
tion of only two subjects of the experimental group demonstrating positive 
agglutinations in serum diluted 1:20. Therefore, this is evidence that 
the periodontal patients in this study did not have rheumatic disease; and 
the two subjects with positive sera agglutination at 1:20, probably fall 
into the category of normal persons with rheumatoid factor, as described 
by Moskovitz (1975). Perhaps it is possible that agglutinations seen at 
1:10 dilution in the absence of rheumatoid arthritis, is due to the pre-
sence of rheumatoid factor associated with the generalized chronicity of 
antigenic-mitogenic stimulation characteristic of periodontal disease. 
The potential etiology of rheumatoid factor production in periodon-
tal disease may possibly be two fold. First, rheumatoid factor may be 
induced by the mitogenicity, adjuvanticity and immunogenicity of gram 
negative bacterial lipopolysaccharides. Chiller, Skidmore, Morrison and 
Weigle (1973) have demonstrated the mitogenic effect of lipopolysaccharide 
could be related to a particular structural region of the molecule, namely 
the lipid A region. Lipid A has been demonstrated in association with 
gram negative bacteria, endotoxin and periodontal disease. Tanner, Haf-
fer, Brathall, Viscontis and Socransky (1979) have shown the subgingival 
microbiota in advanced periodontal disease to be predominated by gram 
negative rods. Slots (1979) determined the microflora of advanced adult 
periodontitis was comprised mainly of gram negative anaerobic rods. 
Schwartz, Stinson and Parker (1972) have shown endotoxin localized in 
crevicular epithelium by autoradiography. Simon, Goldman, Reuben, Breit-
man and Baker (1972) have shown endotoxin in gingival exudate and with 
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increasing severity of gingival lesions associated with an increase in 
the numbers of gram negative bacteria. Endotoxin of gram negative bac-
teria has further been demonstrated in dental plaque by Mergenhagen, 
Bladen and Hsu (1966) and root surfaces of periodontally involved teeth 
by Jones and O'Leary (1978) and Aleo, DeRenzis, Farber and Varboncouer 
(1974). Therefore, the basis of gram negative bacterial induction of 
rheumatoid factor in periodontal disease by lipopolysaccharide appears 
substantially evident. It has been shown by Izui, Eisenberg and Dixon 
(1979) that bacteria associated with lipopolysaccharide causing infection 
when administered to rats may trigger the production of IgM-rheumatoid 
factor. 
Secondly, immune complexes demonstrated by Berglund (1971) in perio-
dontitis must be considered as a potential causitive agent of rheumatoid 
factor production. It has been shown that upon antigen combining with 
antibody the Fab portions of the molecule assume a 180° angle in respect 
to each other. As the immune complex is formed an alteration in the ter-
tiary structure of the antibody may occur revealing new or buried anti-
genic determinants in the Fe fragment of the IgG molecule. Vaughn (1972). 
Plasma cells might then produce autoantibodies or rheumatoid factors 
against these newly revealed antigenic determinants. This may be a factor 
in periodontitis but additional studies to determine the presence of 
Ag-Ab complexes are needed. 
Subjects with positive reactions for rheumatoid factor in subgingi-
val plaque samples also demonstrated corresponding positive reactions in 
samples of stimulated saliva. Theoretically, perhaps, chronic antigenic 
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stimulating substances, for example, lipopolysaccharides, may travel from 
gingival tissue to regional lymph nodes resulting in rheumatoid factor 
production by plasma cells in germinal centers. It has been shown by 
Mellors, Nowoslawski and Korngold (1961) that rheumatoid factor is pro-
duced in germinal centers of lymph nodes. Rheumatoid factors may then be 
transported to salivary gland tissue and secreted with saliva. Studies, 
are needed to determine if lipopolysaccharide is transported from gingiva 
to the lymphoid tissues in salivary glands. In this event, rheumatoid 
factor could be locally produced and secreted with saliva; secretory IgM 
has been reported in saliva by 8randtzaeg (1966). 
The production of rheumatoid factor in periodontitis in the absence 
of rheumatoid arthritis possibly could occur, if the patient has geneti-
cally programmed 8-cells for rheumatoid factor production. Rheumatoid 
factor can be produced by patients without rheumatoid arthritis as Koop-
man and Schrohenloher (1980) have shown 8-cells from non-rheumatoid pa-
tients, stimulated by poke weed mitogen, were capable of producing IgM-
rheumatoid factor. 
It has been suggested that rheumatoid factors have a protective 
role in the body•s defense. Vaughn (1972) have shown that rheumatoid 
factors have the ability to combine with soluble antigen-antibody com-
plexes and thereby render them less soluble and more easily cleared by 
the reticuloendothelial system. 
The presence of IgM-rheumatoid factor has been reported to inhibit 
some in vitro complement dependent systems, and this has given rise to a 
concept that rheumatoid factor could be protective, although in vivo 
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analogues are lacking, according to Johnson and Faulk (1976). 
Supportive evidence of the complement fixing properties of rheuma-
toid factor is reported by Goodman (1961) and Franklin (1961) who demon-
strate an antigenic site on gamma globulin for rheumatoid factor binding; 
and Ishizaka, Ishizaka and Sugakara (1962) showing binding sites for com-
plement component c1; both sites are located on the Fe fragment of IgG. 
Therefore, if rheumatoid factor binds to and occupies the Fe fragment of 
IgG, and blocks complement binding site, the rheumatoid factor molecule 
must provide the only available site to bind complement, in such case. 
Further support of the complement activation by rheumatoid factor 
is reported by Ashe and Notkins (1971) who demonstrate enhanced neutrali-
zation of herpes simplex virus by rabbit and human antibody complement by 
the addition of IgM-rheumatoid factor. Furthermore, McCormick, Day, 
Morris and Hill (1969) showed more exaggerated complement associated le-
sions of experimental nephrotoxic nephritis induced in vivo, when IgM 
rheumatoid factor was present. 
Complement activation by either immune complexes or endotoxin 
appears to be present in periodontal disease, also. Schenkein and Genco 
(1977) and Attstrom, Laurel, Larsson and Sjoholm (1974) demonstrated a 
marked decrease in c3 and c4 levels in gingival fluid as compared to 
serum. The above findings are felt to be suggestive of complement ac-
tivation and consumption during periodontal inflammation. 
Similarly, Hedberg (1964) and Pekin and Zvaifler (1964) have shown 
reduced complement levels in synovial fluid due to antigen-antibody re-
actions, in rheumatoid arthritis. 
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Tesar and Schmid (1970) have shown IgM rheumatoid factor has the 
capability of transforming soluble complexes to complement fixing aggre-
gates, making immune complexes more easily phagocytized. Therefore, 
rheumatoid factor may possibly act as another homeostatic mechanism in 
periodontal inflammation and also be partly responsible for complement 
activation and consumption. 
It is an established phenomena, that rheumatoid factor in serum may 
act as a diagnostic and prognostic indicator in rheumatic diseases. For 
example, William and Kunkel (1962) have demonstrated that positive serum 
reaction for rheumatoid factor in patients with bacterial endocarditis, 
upon cure, revert to negative. 
In this investigation, one may raise the question: can rheumatoid 
factor be used as an indicator for severity of disease, prognosis and 
possible cure? This may only be determined through additional research. 
The following theory is based on the role of rheumatoid factor in 
the pathogenesis of rheumatoid arthritis described by Taborn and Walker 
(1979), and which is modified in relation to the pathogenesis of perio-
dontal disease. Chronic antigenic stimulating substances, i.e. gram 
negative bacteria derived lipopolysaccharides found in crevicular fluid 
or gingival tissue stimulate production of antibody. Antigen-antibody 
complexes are formed which may produce alteration in the tertiary 
structure of the antibody revealing new antigenic determinants. Such 
antigenic determinants stimulate production of the autoantibody, 
rheumatoid factor. 
At this point it must be stated that theoretically rheumatoid 
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factor production may have at least two origins. Either the IgG-globulin 
becomes immunogenic upon lipopolysaccharide binding as an antigen or 
lipopolysaccharides induce rheumatoid factor directly, in genetically 
programmed B-cells. The generation of a population of competent B-cells 
can provide the autoantibody or rheumatoid factor to react with IgG 
even in the absence of the original antigen, of course, subject to 
other immunologic control factors. One cannot discount the idea of both 
mechanisms operating simultaneously. 
In periodontitis, if immune complexes bound by rheumatoid factor 
form in crevicular fluid, then they may fix and activate complement com-
ponents thereby attracting polymorphonuclear leukocytes and macrophages. 
In the event of chronic antigenic stimulation, lymphocytes and plasma 
cells would continue to proliferate as the disease process becomes more 
chronic. In this case, it could explain why rheumatoid factor levels 
are sustained in crevicular fluid. 
The etiology of rheumatoid factor production in rheumatic diseases 
still is unknown, however a number of theories have been postulated. In 
advanced cases of periodontitis, the association of gram negative bac-
teria and endotoxin found in dental plaque, root surfaces, gingival exu-
date and gingival tissues; may be implicated as the etiologic agent of 
rheumatoid factor production in periodontal disease. Bacterial lipopoly-
saccharides or endotoxins have been associated with inflammatory perio-
dontal disease as reported by Snyderman, Gewurz and Mergenhagen (1968), 
and Snyderman (1972). 
CHAPTER VI 
SUMMARY 
Rheumatoid factor was determined by latex slide agglutination, on 
subgingival plaque samples, stimulated pooled saliva and serum of thirty 
patients with Type III periodontitis. 
Twenty of thirty patients demonstrated positive reactions for 
rheumatoid factor in subgingival plaque, diluted in 0.18 ml of GBS. 
All thirty patients demonstrated positive reactions for rheumatoid 
factor in stimulated saliva. 
Five of the ten full denture patients utilized for control saliva 
demonstrated positive reactions for rheumatoid factor. 
Twenty five of thirty ~xperimental subjects demonstrated positive 
reactions for rheumatoid factor in serum diluted 1:10. 
Blank latex beads, utilized as a parallel control were unreactive, 
to subgingival plaque, saliva and serum. 
Albumin was detected at a mean concentration of .27 g/100 ml. 
The etiology of rheumatoid factor and homeostatic mechanism in 
association with periodontal diseases are discussed and may be due to 
the reported association of gram negative bacterial endotoxin and the 
chronic antigenic stimulating nature of periodontal disease. 
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CHAPTER VII 
CONCLUSIONS 
In the light of this investigation, periodontal disease may be 
placed in perspective with other chronic antigenic stimulating diseases 
associated with rheumatoid factor. 
Further investigation dealing with the role and application of 
rheumatoid factor in chronic periodontal disease is essential and neces-
sitates additional research. 
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